Public Access Records Office
The National Academies
500 5th Street NW
Room KECK 219
Washington, DC 20001
Tel: (202) 334-3543
Email: paro@nas.edu
Project Information

Project Information


Enhancing Global Health Security Through International Biosecurity and Health Engagement Programs


Project Scope:

An ad hoc committee will examine international health security programs and organizations with missions to enhance health security by promoting biosafety, biosecurity, disease surveillance, health security, and biorisk management with foreign partner countries. By engaging experts from countries that actively sponsor such work and building on past work that established overall goals (such as Global Health Security Agenda action package five-year targets), the study committee will address the following questions:

1.        What principles guide successful health security programs?

2.        How can the programs around the world better coordinate and align actions with established targets to ensure that efforts are not duplicated unnecessarily and opportunities are not missed because of gaps in authorities and program practices?

3.       What steps can be taken to ensure that health security programs continue to prioritize biosafety and biosecurity over the next five years?

4.         What gaps are most important for the international community to address to advance global health security over the next five years?

5.        How should the overall mission picture be integrated to make it easier to make budget priorities match policy priorities?

In its report, the study committee will articulate a five-year strategic vision for health security and provide findings and recommendations to address the questions above.

Status: Current

PIN: PGA-CISAC-16-04

Project Duration (months): 12 month(s)

RSO: Guenther, Rita

Topic(s):

Biology and Life Sciences
Conflict and Security Issues
Health and Medicine
Math, Chemistry, and Physics
Policy for Science and Technology


Committee Membership

Committee Post Date: 01/30/2018

Ronald M. Atlas - (Chair)
Ronald M. Atlas is co-chair of the Public and Scientific Affairs Board Biodefense Committee of the American Society for Microbiology (ASM) and professor of biology at the University of Louisville. He has served as president of ASM, as a member of the National Institutes of Health (NIH) Recombinant Advisory Committee, as chair of the National Aeronautics and Space Administration’s Planetary Protection Committee, as chair of the Wellcome Trust Pathogens, Immunology and Population Health Strategy Committee, as a member of the Department of Homeland Security Science and Technology Advisory Committee, and as chair of the Board of Directors of the One Health Commission. He is author of nearly 300 manuscripts and 20 books, and has served on numerous National Academies of Science, Engineering, and Medicine (NASEM) committees. He is a fellow in the American Academy of Microbiology. Atlas is a pioneer of bioremediation and an expert on the clean up of oil spills, and is also an expert in the detection of biothreat agents and the prevention of bioterrorism. He received his B.S. degree from the State University at Stony Brook, his M.S. and Ph.D. degrees from Rutgers, The State University of New Jersey, and D.Sc. (honoris causa) from the University of Guelph.


Nisreen D. Al-Hmoud
Nesreen AL-Hmoud is the director of the Center for Excellence in Biosafety, Biosecurity, and Biotechnology at the Royal (Jordanian) Scientific Society. She conducts research that focuses on the preservation of human health and biodiversity, specifically in the fields of biosafety, water and food safety, and the evaluation of risks from genetically modified organisms. She is particularly interested in international scientific cooperation and works toward the development of scientific capacity that can benefit the broader scientific community, government agencies, local communities, and non-governmental organizations in Jordan and the Middle East and North Africa (MENA) region. She focuses on research that involves a holistic approach to microbiology, molecular biology, virology, toxicology, and ecology. She is a frequent participant at international biosafety meetings, and has attended international governmental meetings at the Biological and Toxin Weapons Convention and the United Nations (UN) 1540 Committee. AL-Hmoud received her B.S. in biology from the University of Jordan, and her M.Phil. and Ph.D. in microbiology from the University of Abertay Dundee in Scotland.
David M. Barash
David Barash is the executive director of the Global Health Portfolio and chief medical officer for the GE Foundation. Barash is also co-chair of the Private Sector Roundtable, a collaboration of several multinational companies to support the work of the Global Health Security Agenda. Barash is a practicing emergency medicine physician with more than 30 years of experience. Prior to joining the GE Foundation, Barash was chief medical officer of Life Care Solutions. Barash was also founder and president of Concord Healthcare Strategies, where he provided strategic and operational expertise to medical technology investors and development stage medical technology companies. He received his B.A. and M.D. degrees from Cornell University, and is a fellow of the American College of Emergency Physicians.
Kavita M. Berger
Kavita Berger is a scientist at Gryphon Scientific where she is building new programs on international bioengagement and science policy. She began her career in science and security policy in 2005 at the American Association for the Advancement of Science (AAAS), where she developed activities that engaged science policy and security experts on topics ranging from health security to biological weapons, enabling scientists to bring their knowledge and experience to current security policy dialogues and the security policy community to better understand the broader implications of science and technology. She has conducted forward-looking studies, such as the 2014 evaluation of the security implications of big data in the life sciences. She also has engaged scientists across the MENA region and South Asia since 2009 to work together to prevent biosecurity threats. Her work in the MENA region promoted partnership and trust among U.S. and regional scientists to jointly reduce biological risks. Prior to joining AAAS, Berger conducted her post-doctoral research at the Emory Vaccine Center on pre-clinical research and development of HIV and smallpox vaccines. She received her B.S. in molecular genetics at The Ohio State University and her Ph.D. in genetics and molecular biology at Emory University.
Kenneth W. Bernard
Rear Admiral Kenneth Bernard, U.S. Public Health Service, USPHS (Ret.), is an independent consultant on security and health issues. He served as special assistant to President Gerorge W. Bush for Biodefense on the Homeland Security Council from 2002 to 2005. Admiral Bernard chaired the White House Biodefense Policy Coordinating committee, and drafted decision directives for President Bush on both “Biodefense for the 21st Century” and agricultural bioterrorism, and he was the White House point person on implementation of the Project Bioshield Act. After September 11, 2001, he created the position of special adviser for National Security, Intelligence, and Defense to the Secretary of Health and Human Services (HHS). Prior to this service, Bernard worked as a professional staff member in the U.S. Senate, served on President Clinton’s National Security Council staff, as the International Health Attaché at the U.S. Mission to the UN in Geneva, Switzerland, as the associate director for Medical and Scientific Affairs in the Office of International Health at HHS, as International Health Policy Adviser to the director of the U.S. Peace Corps, and as a medical epidemiologist at the Centers for Disease Control and Prevention. Admiral Bernard earned his M.D. from the University of California, Davis, and a diploma in tropical medicine and hygiene from the London School of Hygiene and Tropical Medicine. He is board certified in internal medicine.


David R. Franz
David R. Franz is an independent consultant. He served in the U.S. Army Medical Research and Materiel Command for 23 of 27 years on active duty and retired as colonel. He served as commander of the U.S. Army Medical Research Institute of Infectious Diseases and as deputy commander of the Medical Research and Materiel Command. Prior to joining the Command, he served as group veterinarian for the 10th Special Forces Group (Airborne). Franz was the chief inspector on three UN Special Commission biological warfare inspection missions to Iraq, and served as technical advisor on long-term monitoring. He also served as a member of the first two U.S.-U.K. teams that visited Russia in support of the Trilateral Joint Statement on Biological Weapons and as a member of the Trilateral Experts’ Committee for biological weapons negotiations. He is a member of the National Academy of Sciences’ Committee on International Security and Arms Control. He previously served on the Board on Life Sciences and the Health and Human Services National Science Advisory Board for Biosecurity. Franz also co-chaired NASEM’s Committee on Strengthening and Expanding Department of Defense’s Cooperative Threat Reduction program. Franz holds a D.V.M. from Kansas State University and a Ph.D. in physiology from Baylor College of Medicine.
Gregory C. Gray
NUS Medical School, Singapore, and as a professor of global health at Duke Kunshan University in China. Gray has conducted diverse epidemiological studies of infectious diseases for 25 years on 5 continents. Much of his work has involved identifying risk factors for occupational diseases, particularly for infectious diseases in a wide variety of occupational groups. He has served on numerous national expert advisory committees including those associated with the U.S. Armed Forces Epidemiological Board, the Infectious Disease Society of America, and the National Academy of Medicine (NAM). Currently, he serves on the editorial board for the journals Influenza and Other Respiratory Viruses and Tropical Diseases, Travel Medicine and Vaccines. Gray earned his M.P.H. from the Johns Hopkins School of Public Health, and his M.D. from the University of Alabama at Birmingham.
Gerald T. Keusch
Gerald Keusch is professor of medicine and global health at Boston University where he serves as an associate director of the National Emerging Infectious Diseases Laboratory. He is board certified in Internal Medicine and Infectious Diseases. His research has ranged from the molecular pathogenesis of tropical infectious diseases to field research in nutrition, immunology, host susceptibility, and the treatment of tropical infectious diseases and HIV/AIDS. He has held faculty positions at Tufts University, where he was director of training programs in infectious disease. He served as director of the NIH Fogarty International Center. Keusch is the recipient of three major awards from the Infectious Diseases Society of America (the Oswald Avery and Alexander Fleming awards for research and training excellence, and the Finland Lectureship). Keusch attended Columbia College and earned his M.D. from Harvard Medical School. He is also a member of the National Academy of Medicine, and co-chaired the 2017 NASEM report, Integrating Clinical Research into Emergency Response: The Ebola Experience.
John E. Lange
Ambassador John E. Lange (Ret.) is senior fellow for Global Health Diplomacy at the UN Foundation. Previously, at the Bill & Melinda Gates Foundation, Lange worked with African governments to improve public health. He has served as co-chair of the Global Polio Eradication Initiative’s Polio Partners Group since its inception. Ambassador Lange had a 28-year career in the Foreign Service at the U.S. Department of State, including service as special representative on Avian and Pandemic Influenza, Deputy Inspector General, Deputy U.S. Global AIDS Coordinator, associate dean at the Foreign Service Institute, Ambassador to Botswana, and Charge d'Affaires at the U.S. Embassy in Dar es Salaam during the August 7, 1998, terrorist bombing, for which he received the State Department’s Distinguished Honor Award for skilled leadership and extraordinary courage. He serves on the Global Health Diplomacy Network. Ambassador Lange earned his B.A. from the University of Wisconsin-Madison, a M.S. from the National War College, and J.D. from the University of Wisconsin Law School. He was admitted to the bar in Wisconsin and New York, and studied at The Hague Academy of International Law.
Mobolaji O. Odubanjo
M. Oladoyin Odubanjo is the executive secretary of the Nigerian Academy of Science and the chairman of the steering committee of the International Network for Government Science Advice. He is a fellow of the Royal Society of Public Health and the chairman of the Association of Public Health Physicians of Nigeria (Lagos Chapter). He was a medical officer in the employment of a state government in Nigeria which saw him work in 5 hospitals across the state. He has served on the Board of the Global Organisation for Maternal and Child Health USA. He is also an advisor to the Centre for Palliative Care Nigeria, an organization at the forefront of establishing palliative medicine in Nigeria. Odubanjo earned his MBBS and his diploma in child health from the University of Ibadan, and his M.Sc. in public health from University College London’s Institute of Child Health.

Events



Location:

National Academy of Sciences Building
2101 Constitution Ave NW, Washington, DC 20418
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Rita S. Guenther
Contact Email:  rguenther@nas.edu
Contact Phone:  202-334-2359

Agenda
Enhancing Global Health Security through International Biosecurity and Health Engagement Programs

July 16, 2018

8:00 - 9:00 CLOSED SESSION


9:15 - 3:15 OPEN SESSION

9:15 – 9:30 Welcome and Introductions

RON ATLAS
Committee Chair

SESSION I
Study Sponsors: Cooperative Biological Engagement Program (CBEP) of the Defense Threat Reduction Agency (DRTA)

9:30 – 10:30 CBEP Program in Detail

LANCE BROOKS
Division Chief
Cooperative Biological Engagement Program
Defense Threat Reduction Agency
U.S. Department of Defense

CARL NEWMAN
Science Branch Chief/Chief Scientist
Cooperative Biological Engagement Program
Defense Threat Reduction Agency
U.S. Department of Defense

10:30 – 11:00 Q&A

11:00 – 11:15 Coffee Break

11:15 – 11:45 The Development of Policy Guidance for CBEP

HILA HANIF
Countering WMD, OSD Policy
U.S. Department of Defense

11:45 – 12:15 Discussion

12:15 – 1:15 Lunch Break

SESSION II
CBEP Projects and Programs in Practice: Detailed Discussion with Implementers


1:15 – 1:45 Building Bridges: Inside View of CBEP Engagements

JULIE FISCHER
Director, Elizabeth R. Griffin Program - GHSS
Research Associate Professor of Microbiology and Immunology
Georgetown University Medical Center


1:45 – 2:15 Global Health Security Partnerships: Implementing Cooperative Research

KENNY YEH
Senior Advisor Science, Program Development
Global Health Surveillance & Diagnostics
MRIGlobal

2:15 – 2:45 Building Bridges: Inside View of CBEP Engagements

PATTY OLINGER
Asst. Vice President – Office of Research Administration
Exec. Director – EHSO
Emory University

2:45 – 3:15 Discussion

3:15 Adjourn Public Session

Is it a Closed Session Event?
Yes



Location:

Keck Center
500 5th St NW, Washington, DC 20001
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Rita S. Guenther
Contact Email:  rguenther@nas.edu
Contact Phone:  202-334-2359

Agenda
DRAFT PUBLIC AGENDA

Enhancing Global Health Security through International Biosecurity and Health Engagement Programs

April 23, 2018

SESSION I Study Sponsors: Cooperative Biological Engagement Program (CBEP) of the Defense Threat Reduction Agency (DRTA)

12:30 – 12:40 Welcome and Introductions
VICE CHAIR

12:40 – 1:00 CBEP Program Overview and Charge to the Committee
LANCE BROOKS (CONFIRMED)
Division Chief, CBEP

CARL NEWMAN (CONFIRMED)
Science Branch Chief/Chief Scientist

1:00 – 1:15 Discussion

1:15 – 1:30 CBEP in the Context of DOD’s Larger Portfolio of Work
JENNIFER WALSH (CONFIRMED)
Principal Director, Countering WMD, OSD Policy

1:30 – 2:00 Discussion

2:00 – 2:15 Coffee Break

SESSION II Coordinating Efforts: U.S. Government Global Health Security Partners

2:15 – 2:30 Department of State: Biosecurity Engagement Program
SAPANA VORA (CON0FIRMED)

2:30 – 2:45 Department of Defense: Health Readiness
TERRY M. RAUCH (CONFIRMED)

2:45 – 3:00 Centers for Disease Control and Prevention
REBECCA MARTIN (CONFIRMED)
JOEL MONTGOMERY (CONFIRMED)

3:00 – 3:15 Health and Human Services
GARRETT GRIGSBY (INVITED)

3:15 – 3:30 USAID
DENNIS CARROLL (CONFIRMED)

3:30 – 3:45 Senate Foreign Relations Committee
Senate Armed Services
Health, Education, and Labor
TBD

3:45 – 4:15 Discussion

4:15 – 5:00 Public Comment Period


April 24, 2018

SESSION III Understanding the Global Health Security Agenda (GHSA), One Health, and U.S. Policy Regarding Global Bioengagement Programs

9:00 – 9:15 Overview of U.S. Biodefense Strategy and U.S. Engagement via
GHSA
HILLARY CARTER (CONFIRMED)
National Security Council

9:15 – 9:30 Coordinating U.S. GHSA Efforts
MATT WEST (CONFIRMED)
BRETT GOODE (CONFIRMED)
Department of State

9:30 – 9:45 Coordinating Global GHSA Efforts GHSA Consortium
ASHLEY ARABASADI (CONFIRMED)
GHSA Consortium

9:45 – 10:00 Coordinating Private Sector Engagement: The GHSA Private
Sector Roundtable
ALLEN TENNENBERG (CONFIRMED)
GHSA Private Sector Roundtable

10:00 – 10:15 International Health Regulations and Joint External
Evaluations
REBECCA KATZ (CONFIRMED)
Georgetown University

10:15 – 10:45 Discussion

10:45 – 11:00 Break

SESSION IV International Perspectives on Enhancing Global Health Security
through Biosecurity and Health Engagement Programs

11:00 – 12:00 Panel Discussion with Representatives of Countries Engaged in
Similar Health Security Efforts

Robin Davies (INVITED)
INDO-PACIFIC HEALTH SECURITY INITIATIVE, AUSTRALIA

Tomoya Saito and Hiroyuki Hori (INVITED)
MINISTRY OF HEALTH, LABOUR AND WELFARE, JAPAN

Ganglip Kim (INVITED)
MINISTRY OF HEALTHCARE POLICY, SOUTH KOREA

Outi Kuivasniemi (CONFIRMED)
MINISTRY OF SOCIAL AFFAIRS AND HEALTH, FINLAND

Guy Vernet (CONFIRMED)
FONDATION MERIEUX, FRANCE

Douwe Kuperus and Stef Stienstra (INVITED)
NETHERLANDS

12:00 – 12:30 Discussion

12:30 – 1:15 Lunch Break

1:15 – 2:00 Panel Discussion on Multilateral Global Health Security
Efforts

Kazunobu Kojima (INVITED)
WORLD HEALTH ORGANIZATION

Anna Wickstrom-Nojgaard (CONFIRMED)
MINISTRY OF SOCIAL AFFAIRS AND HEALTH, FINLAND

Trevor Smith (INVITED)
GLOBAL PARTNERSHIP

2:00 – 2:30 Discussion

2:30 – 2:45 Coffee Break

SESSION V Perspectives from Non-Governmental Organizations Engaged in
Global Health Security Efforts

2:45 – 3:00 Taking the Long View: Evolving U.S. Engagement in Global
Health Security
Beth Cameron
NTI (CONFIRMED)

3:00 – 3:15 Building Bridges: An Implementer’s View of CBEP Efforts
Julie Fischer, Georgetown University (CONFIRMED)

3:15 – 3:30 Exploring Alternative Approaches: A Private Foundation
Experience

Scott Dowell and David Blazes, Gates Foundation (CONFIRMED)

3:30 – 3:45 Exploring Alternative Approaches: A One Health Approach to
Emerging Disease Surveillance and Prevention
Peter Daszak, EcoHealth Alliance (CONFIRMED)

3:45 – 4:30 Discussion

4:30 – 5:00 Public Comment Period

5:00 Adjourn Public Session

Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

Nisreen Alhmoud
David Barash
Kavita Berger
Ken Bernard
David Franz
Gregory Gray
Gerald Keusch
John Lange
Doyin Odubanjo



The following topics were discussed in the closed sessions:

Reactions from presentations during Open Sessions.
Additional information needed during future meetings.


The following materials (written documents) were made available to the committee in the closed sessions:

None

Date of posting of Closed Session Summary:
July 06, 2018

Publications

  • Publications having no URL can be seen at the Public Access Records Office
Publications

No data present.